Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-makingChen-Lu Lian aGuan-Qiao Li bPing Zhou aJun Wang aZhen-Yu He cSan-Gang Wu aThe Breast
The anatomic stage groups (ASG) have been arguably the most powerful in predicting breast cancer (BC) outcomes. Recognizing the prognostic influence of histologic grade and receptor status, the 8th AJCC mandates their incorporation into the newly established prognostic stage groups (PSG). This stagin...
The AJCC 8th edition staging is effective for cancer diagnosed beginning January 1, 2018. Calculation of stage has been made less complicated and easier to interpret and soon will be available as an app for mobile phones. Examining the tables starting on the left, the T, N, and M ...
Pathological complete response (pCR) was defined as the absence of invasive cancer in the breast and axillary lymph nodes [34]. The AJCC Staging 8th edition has been used in the clinical and pathological TNM classification [35]. The tumor subtypes according to IHC staining were analyzed using ...
Despite increasing women’s life expectancy, disparities in age-specific treatment, particularly among older women, continue to be insufficiently explored [4,11,12,13,22]. The AJCC 8th edition breast cancer staging system integrates biomarkers with anatomical staging to improve prognostic accuracy and ...
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer running head: Revisiting estrogen positive tumors in 8 th AJCC staging era Ryu, J.M.; Lee, S.K.; Lee, J.E.; Nam, S.J.; Yu, J.; Choi, H.J.; Kim, I.; Kim, S.W....
The 8th edition American Joint Committee on Cancer (AJCC) prognostic staging system (PS) has been validated numerous times; however, the prognostic value of PS for breast cancer based on molecular subtype has rarely been explored. This study aimed to investigate the prognostic value of PS in Chi...
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ Breast Cancer. 2020;6(1):17. doi:10.1038/s41523-020-0156-0PubMedGoogle ScholarCrossref 11. Amin MB, Edge SB, Greene FL, et al et al. AJCC Cancer Staging Manual. 8th ...
Breast cancer is the second most common malignancy in women (after nonmelanoma skin cancer). In the US, the lifetime risk of a woman developing breast cancer is approximately 13%. The most importan...
K. et al. Implications for breast cancer restaging based on the 8th edition AJCC staging manual. Ann. Surg. 271, 169–176. https://doi.org/10.1097/SLA.0000000000003071 (2020). Article PubMed Google Scholar Isaev, K. et al. Pan-cancer analysis of non-coding transcripts reveals the ...